Congress Should Reclassify Marijuana

February 17, 2015
Marijuana Business Daily

Congress Should Reclassify Marijuana, Cato Institute Says

Medical cannabis companies and users would benefit if Congress rescheduled marijuana as a Schedule II drug, according to a report by the Cato Institute.

The libertarian think tank said reclassifying marijuana at the federal level would cut into black market sales, reduce law enforcement expenditures and free marijuana users from the threat of arrest and monetary penalties.

The federal government defines Schedule I drugs – including marijuana – as having a high risk of abuse and addiction and offering no medical benefits.

The Cato report recommends that Congress should rescheduled marijuana as a Schedule II drug. That would “mean that medical provision in current or future medical marijuana states would not be inconsistent with federal law,” the Cato Institute said.

Allowing physicians to prescribe marijuana would also… more

Facebooktwittergoogle_plusredditpinterestlinkedinmailby feather

There are no comments so far

Leave a Comment

Don't worry. We never use your email for spam.

Don't worry. We never use your email for spam.